v3.26.1
Shareholders' Equity - Restricted Stock (Details) - Restricted Stock Unit (RSU) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting period 3 years    
Vested in period, fair value $ 1,763,433 $ 1,303,187  
Stock based compensation expense 1,524,902 $ 1,244,416  
Compensation cost not yet recognized $ 4,146,227    
Weighted average period for recognition 1 year 4 months 13 days    
Number outstanding      
Balance non-vested Stock at beginning of period (in shares) 560,970 491,536  
Granted (in shares) 488,283 300,052  
Vested (in shares) (267,461) (230,618)  
Balance non-vested Stock at end of period (in shares) 781,792 560,970 491,536
Weighted Average Remaining Life      
Balance non-vested Stock at end of period (in years) 1 year 8 months 15 days 1 year 7 months 9 days 1 year 8 months 26 days
Granted (in years) 1 year 6 months 1 year 11 months 1 day  
Weighted Average Grant Date Fair Value      
Weighted Average Grant Date Fair Value , beginning of period $ 5.77 $ 5.59  
Weighted Average Grant Date Fair Value, Granted 4.78 5.97  
Weighted Average Grant Date Fair Value, Vested 5.6 5.65  
Weighted Average Grant Date Fair Value, end of period $ 5.06 $ 5.77 $ 5.59
Management, Employees, and Board Of Directors      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Weighted average market price at grant date (in dollars per share) $ 4.78 $ 5.97  
Number outstanding      
Granted (in shares) 488,283 300,052  
Maximum | Management, Employees, and Board Of Directors      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting period 4 years    
Minimum | Management, Employees, and Board Of Directors      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting period 3 years